Expertise in
7
conditions

Shane W. English

Ottawa, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Ottawa, ON, CA 

Overview

Shane English practices in Ottawa, Canada. Mr. English is highly rated in 7 conditions, according to our data. His top areas of expertise are Subarachnoid Hemorrhage, Gastrointestinal Bleeding, Pneumonia, Peptic Ulcer, and Kidney Transplant.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Ottawa, ON, Canada
Other Locations
Quebec, St. Joseph's Healthcare Hamilton Research Institute, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Dalteparin
Study Phase: Phase 3
Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial
Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Biological
Study Drug: UC-MSCs
Study Phase: Phase 2
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: Pantoprazole
Study Phase: Phase 3
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
Enrollment Status: Unknown
Publish Date: October 13, 2023
Intervention Type: Drug
Study Drugs: IFN-Beta1a, Remdesivir
Study Phase: Phase 3
Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)
Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

133 Total Publications

Excitatory amino acid inhibitors in adults with acute moderate to severe traumatic brain injury: a systematic review and meta-analysis.
Excitatory amino acid inhibitors in adults with acute moderate to severe traumatic brain injury: a systematic review and meta-analysis.
Journal: BMJ open
Published: March 19, 2026

Frequently Asked Questions about Shane W. English

Is Shane W. English a top-rated expert for Subarachnoid Hemorrhage?

MediFind is an objective health platform that identifies experts based on real-world data. Shane W. English is classified as an Distinguished expert for Subarachnoid Hemorrhage, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shane W. English participate in research or clinical trials?

Yes. Shane W. English has published 133 articles and abstracts on conditions like Subarachnoid Hemorrhage. You can view a list of Shane W. English's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. English's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile